Lexpos News

Community Pharmacy England will be holding a webinar on Wednesday, 11th February at 7:30 pm to help community pharmacy owners complete the Data Security and Protection Toolkit (DSPTK) 2026.  We have worked with the NHS DSPTK team on the new Toolkit requirements and made improvements to this year’s Toolkit. Both our organisations are eager to support pharmacy owners as you work your way through the Toolkit.  During the webinar, representatives from Community Pharmacy England and the NHS DSPTK team will discuss the Toolkit questions, talk delegates [...]

The post Register for our Data Security and Protection Toolkit 2026 Workshop appeared first on Community Pharmacy England.

Trade press Recent reports highlight that nine in ten pharmacies have experienced verbal or physical intimidation from patients who were not eligible for COVID-19 vaccinations, according to data from the National Pharmacy Association. Community Pharmacy England’s current sector Opinion Poll includes important questions about patient abuse towards pharmacy staff. Patient aggression, abuse and intimidation are [...]

The post Confusion over COVID vaccinations and rising patient abuse put pressure on pharmacies appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (16/01/2026) confirmed the following initial list of price concessions for January 2026: Drug Pack size Price concession Amoxicillin 250mg/5ml oral suspension 100 £1.44 Aspirin 75mg dispersible tablets 28 £2.19 Aspirin 75mg dispersible tablets 100 £7.82 Betamethasone 500microgram soluble tablets sugar free 100 £47.89 Carbocisteine 375mg [...]

The post January 2026 Price Concessions 1st Update appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg sublingual tablets. MSN/2026/002 Tier 2 – Medium impact Date of issue: 15 January 2026 Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg sublingual tablets were discontinued on 5th January 2026. Various strengths (0.7mg/0.18mg, 1.4mg/0.36mg, 5.7mg/1.4mg, 8.6mg/2.1mg, and 11.4mg/2.9mg) of [...]

The post Medicine Supply Notification: Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets appeared first on Community Pharmacy England.

The NHS Business Services Authority (NHSBSA) has published the questions which will be included in the 2025/26 Pharmacy Quality Scheme (PQS) declaration so pharmacy owners can view these ahead of making their declaration when the declaration window opens. The questions are available on the NHSBSA PQS hub page; scroll down to the ‘PQS 2025/26’ section where [...]

The post PQS declaration questions published appeared first on Community Pharmacy England.